NMD4C Investigators’ Research Named to Quebec Science Magazine’s Top 10 Discoveries of 2023

The 31st edition of the Quebec Science magazine’s Top 10 Discoveries of the Year has recognized a publication from NMD4C investigators in their 2023 list of top scientific discoveries from Quebec-based researchers.

“Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1” is published in Nature Communications, from Dr. Elise Duchesne, Dr. Nicolas Dumont, and Dr. Cynthia Gagnon as a co-author.

Check out the Quebec Science magazine’s article here (available in French), or read the full publication in the journal of Nature Communications.

NMD4C investigators' research named to Quebec Science Magazine's top 10 discoveries of 2023

Read next...

NEWS_Scheduled Website Maintenance

Scheduled Maintenance

Please note that this website, imPORTND, and the NNLS training platform will undergo maintenance from July 23 until July 27, 2026.

NMD4C Talent Pool

Discover Neuromuscular Talent Across Canada

The NMD4C Neuromuscular Talent Pool is now live with new trainees! We invite supervisors and research groups to explore the Talent Pool to identify candidates whose skills, experience, and interests align with your work and upcoming positions. Trainees interested in being included in the Neuromuscular Talent Pool can register by completing the short form, uploading a CV and brief personal statement outlining their experience, interests, and career goals. For more information and to access the Talent Pool, please visit our website.

2026 NMD4C Annual Meeting Registration is Open

Join Us at the 2026 NMD4C Annual Meeting on 25 September

The 2026 NMD4C Annual Meeting will take place in Calgary on Friday, September 25, 2026. The agenda will feature a brief network update, trainee and early-career recognitions, flash talks, a health economics research showcase, and a series of cross‑disciplinary and parallel clinical/pre‑clinical discussion sessions to explore key topics, including advocacy and therapy access, strategies to sustain and strengthen pre-clinical programs, and network sustainability and strategic planning.